Navigation Links
Upsher-Smith Launches B-Nexa® Prescription Prenatal Vitamin With B Vitamins and Ginger for Nausea and Vomiting of Pregnancy
Date:1/23/2012

MAPLE GROVE, Minn., Jan. 23, 2012 /PRNewswire/ -- Pregnant women who suffer from nausea and vomiting of pregnancy (NVP) now have a new option: B-Nexa®, a prescription prenatal vitamin launched today by Upsher-Smith Laboratories, Inc.  B-Nexa® is designed specifically with B vitamins and ginger to help calm NVP, also known as morning sickness, the most common symptom of pregnancy.(1,2)  "Morning sickness" is not the best term to accurately describe symptoms of NVP because the condition affects 83% of pregnant women throughout the day.(2,3) 

(Photo:  http://photos.prnewswire.com/prnh/20120123/NY39344 )

"B-Nexa® is a new option in the prenatal nutrition market that has been designed to help calm nausea and vomiting of pregnancy, with vitamin B6 and ginger, while also providing women with essential folic acid," said Wesley Mark Todd, MD, Senior Director Medical Affairs, Upsher-Smith Laboratories, Inc. "With the launch of B-Nexa®, Upsher-Smith is pleased to have another opportunity to demonstrate our commitment to women's prenatal health."

Taken once or twice daily, B-Nexa® contains vitamin B6 and ginger to help calm nausea and vomiting during pregnancy.  Each antihistamine-free tablet also contains 1.2 mg folic acid for expectant moms and developing babies.(1)  The American College of Obstetricians and Gynecologists (ACOG) recommends vitamin B6 as a first-line approach for morning sickness, and also suggests ginger as a non-drug option.(4)  

For more information about B-Nexa®, visit http://www.b-nexa.com.

About NVP
Although commonly known as morning sickness, NVP can occur at any time throughout the day and affects 70 to 85% of pregnant women.  Approximately 50% of pregnant women experience both nausea and vomiting, while 25% experience only nausea. Studies have shown that women taking a multivitamin regularly at the time of conception were less likely to have severe cases of NVP.(4)   In most cases, the condition affects women only during the first and early second trimesters, although up to 15% of women continue to have symptoms throughout pregnancy.(3) 

NVP can cause significant distress in many women and can lead to feelings of anxiety about how the fetus may be affected.  Some women do not seek treatment for morning sickness because of concerns about drug therapy during pregnancy or because they don't know treatments are available.  Even a less severe case of NVP can detract from the joy of pregnancy and can affect a woman's general well being.(5)

Important Safety Information
You should not take more than 1 mg per day of folic acid unless you are under the care of a healthcare professional, as it may mask the symptoms of a potentially more serious condition.

Taking ginger if you have a bleeding disorder or while you are also taking a blood thinner or other medication that affects the blood may increase the risk of bleeding.

Please see the full Prescribing Information for a complete list of warnings and precautions. 
http://b-nexa.com/prescribing-information

About the Nexa® Family of Products
Upsher-Smith Laboratories, Inc. is committed to providing nutritional support to mothers before, during and after pregnancy.  Designed to provide ingredients to help support a healthy pregnancy, the Nexa® family of products includes Nexa® Select Capsules (Rx prenatal vitamin with 325 mg of plant-based DHA, more than any other single gel capsule prescription prenatal vitamin taken once a day),(6-10) PreNexa® Capsules (Rx prenatal vitamin with plant-based DHA) that offers essential nutrition for mom and baby including 1.25 mg folic acid, and B-Nexa® Tablets (Rx prenatal vitamin formulated with B-vitamins and ginger) to help calm nausea and vomiting of pregnancy. To find out more about the Nexa® family of products or to obtain complete prescribing information, visit http://www.nexavitamins.com.

About Upsher-Smith
Upsher-Smith Laboratories, Inc. is a rapidly growing pharmaceutical company that manufactures, distributes, and markets both prescription and consumer products.  Privately held since 1919, the company strives to recognize the unmet healthcare needs of its customers.  Upsher-Smith prides itself on providing safe, effective, and economical therapies to the ever-changing healthcare environment.  For additional information, visit http://www.upsher-smith.com.   

References

(1)  Upsher-Smith Laboratories, Inc., B-Nexa® Prescribing Information.

(2)  Jewell D, Young G. Interventions for Nausea and Vomiting in Early Pregnancy.  Cochrane Database Syst Rev 2003;(4):CD000145.

(3)  Badell M, Ramin S, Smith J. Treatment Options for Nausea and Vomiting During Pregnancy. Pharmacotherapy. 2006;26(9):1273-1287. Accessed on 10/12/11 at www.medscape.com/viewarticle/545629.

(4)  American College of Obstetricians and Gynecologists. ACOG practice bulletin: Nausea and Vomiting of Pregnancy. Obstet Gynecol 2004;103:803–814.

(5)  Einarson A, et al. Treatment of Nausea and Vomiting in Pregnancy.  Motherisk Update. Canadian Family Physician. December 2007;53:2109-2111.

(6)  Nexa Select. [package insert]. Minneapolis, MN: Upsher-Smith Laboratories, Inc; 2010.

(7)  CitraNatal Harmony [package insert]. San Antonio, TX: Mission Pharmacal Company; 2010.

(8)  Natelle One [package insert]. Philadelphia, PA: Azur Pharma, Inc; 2009.

(9)  NeevoDHA [package insert]. Covington, LA: PamLab, LLC; 2011.

(10)  Prefera OB ONE [package insert]. Marietta, GA: Alaven Pharmaceutical LLC; 2011.

 

 


'/>"/>
SOURCE Upsher-Smith Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Elsevier Launches Bilingual International Nursing Skill Training and Management Platform: NursingChina.com
2. iHealth Lab Launches Personalized Web Portal to Store Your Vitals
3. Exagen Diagnostics Launches Cutting-Edge Lupus Diagnostic
4. Neogen Launches Fully Quantitative Lateral Flow Test for DON
5. Ambry Genetics Launches Illumina MiSeq Next-Gen Sequencing Services
6. BioLife Solutions Launches Search Engine Optimized Website and 1,000 Free Samples Offer
7. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
8. GenWay Biotech Launches New Cardiovascular Diagnostic Blood Test at American Heart Association Scientific Sessions 2011
9. Life Technologies Launches 3500 Dx Series Genetic Analyzers for In Vitro Diagnostic Use in China
10. Reaction Biology Launches Recombinant Methyltransferase Line
11. joimax® Launches Numerous Innovations at EuroSpine Milan From 19 To 21 October 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 On ... session at 4,833.32, down 0.22%; the Dow Jones Industrial Average ... 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ), Aralez ... Inc. (NASDAQ: BIND ). Learn more about these ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance Associates® ... provides a free webinar on Performing Quality Investigations: Getting to Root ... CT at no charge. , Incomplete investigations are still a major concern to ...
(Date:6/23/2016)... June 22, 2016  Amgen (NASDAQ: AMGN ... QB3@953 life sciences incubator to accelerate the ... shared laboratory space at QB3@953 was created to help ... obstacle for many early stage organizations - access to ... sponsorship, Amgen launched two "Amgen Golden Ticket" awards, providing ...
(Date:6/22/2016)... Cell Applications, Inc. and StemoniX announced ... up to one billion human induced pluripotent stem ... These high-quality, consistent stem cells enable researchers to ... more time doing meaningful, relevant research. This achievement ... process that produces affordable, reliable HiPSC for life ...
Breaking Biology Technology:
(Date:5/16/2016)...   EyeLock LLC , a market leader of ... an IoT Center of Excellence in Austin, ... of embedded iris biometric applications. EyeLock,s iris ... security with unmatched biometric accuracy, making it the most ... EyeLock,s platform uses video technology to deliver a fast ...
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted to ... of 2015 The gross margin was 49% (27) ... operating margin was 40% (-13) Earnings per share rose ... was SEK 249.9 M (21.2) , Outlook   ... The operating margin for 2016 is estimated to exceed ...
(Date:4/15/2016)... , April 15, 2016 ... the,  "Global Gait Biometrics Market 2016-2020,"  report to ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait biometrics ... of 13.98% during the period 2016-2020. ... angles, which can be used to compute factors ...
Breaking Biology News(10 mins):